These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9533479)

  • 1. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey.
    Bonfiglio G; Carciotto V; Russo G; Stefani S; Schito GC; Debbia E; Nicoletti G
    J Antimicrob Chemother; 1998 Feb; 41(2):307-10. PubMed ID: 9533479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibiotic susceptibility and occurrence of ESBL in Pseudomonas aeruginosa strains isolated from different clinical specimens].
    Sacha PT; Jakoniuk P; Wieczorek P; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2004; 56(3):263-73. PubMed ID: 15773503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance].
    Dambrauskiene A; Adukauskiene D; Jeroch J; Vitkauskiene A
    Medicina (Kaunas); 2009; 45(1):1-7. PubMed ID: 19223699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S; Sawa A; Kamiya A; Mizuno H
    J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenemase-producing Pseudomonas aeruginosa in UK.
    Woodford N; Palepou MF; Babini GS; Bates J; Livermore DM
    Lancet; 1998 Aug; 352(9127):546-7. PubMed ID: 9716067
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Goodlet KJ; Nicolau DP; Nailor MD
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa: a multicentric study of antibiotic resistance (1999-2000)].
    Kalai S; Jouaihia W; Mahjoubi F; Ghozzi R; Thabet L; Ben Rejeb S; Hammami A; Kechrid A; Ben Hassen A
    Tunis Med; 2004 Dec; 82(12):1070-4. PubMed ID: 15822507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    Gerçeker AA; Gürler B
    J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K; Ishida A; Chinzei T
    Jpn J Antibiot; 2002 Apr; 55(2):181-6. PubMed ID: 12071095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of meropenem, a new carbapenem, against imipenem-resistant Pseudomonas aeruginosa and Xanthomonas maltophilia.
    García-Rodríguez JA; García Sánchez JE; Muñoz Bellido JL; García Sánchez E; García García MI
    J Chemother; 1991 Jun; 3(3):143-6. PubMed ID: 1919651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ansorg R; Müller KD; Wiora J
    Chemotherapy; 1990; 36(3):222-9. PubMed ID: 2110878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of beta-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey.
    Bonfiglio G; Laksai Y; Franchino L; Amicosante G; Nicoletti G
    J Antimicrob Chemother; 1998 Dec; 42(6):697-702. PubMed ID: 10052891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
    Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative bactericidal activity of imipenem and other antibiotics against Pseudomonas aeruginosa].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):472-6. PubMed ID: 3136428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
    Vojtová V; Kolár M; Hricová K; Uvízl R; Neiser J; Blahut L; Urbánek K
    New Microbiol; 2011 Jul; 34(3):291-8. PubMed ID: 21811750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.